Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A survey of patients with inflammatory skin recurrence corresponding to the area of previous irradiation after postoperative radiotherapy for breast cancer.
Tsujino K, Kashihara K, Kotani S, Hayakawa K, Imanaka K, Takada Y, Uno T, Hirata H, Kaneyasu Y, Sekiguchi K, Ogo E, Hiratsuka J, Yoden E, Soejima T. Tsujino K, et al. Among authors: hayakawa k. J Radiat Res. 2011;52(6):797-803. doi: 10.1269/jrr.11010. Epub 2011 Oct 14. J Radiat Res. 2011. PMID: 21997194 Free article.
Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, Suzuki K, Uno T, Tokumaru S, Takayama M, Sekiguchi K, Matsumoto Y, Michimoto K, Oguchi M, Hayakawa K. Niibe Y, et al. Among authors: hayakawa k. Gynecol Oncol. 2006 Nov;103(2):435-8. doi: 10.1016/j.ygyno.2006.03.034. Epub 2006 May 4. Gynecol Oncol. 2006. PMID: 16677691
Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000.
Niibe Y, Kenjo M, Kazumoto T, Michimoto K, Takayama M, Yamauchi C, Kataoka M, Suzuki K, Ii N, Uno T, Takanaka T, Higuchi K, Yamazaki H, Tokumaru S, Oguchi M, Hayakawa K; Japanease Isolated Para-Aortic Lymph Node Recurrence of Uterine Cervical Carcinoma Study Group. Niibe Y, et al. Among authors: hayakawa k. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1366-9. doi: 10.1016/j.ijrobp.2006.07.1384. Int J Radiat Oncol Biol Phys. 2006. PMID: 17126206
High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y, Kenjo M, Onishi H, Ogawa Y, Kazumoto T, Ogino I, Tsujino K, Harima Y, Takahashi T, Anbai A, Tsuchida E, Toita T, Takemoto M, Yamashita H, Hayakawa K. Niibe Y, et al. Among authors: hayakawa k. Jpn J Clin Oncol. 2010 Aug;40(8):795-9. doi: 10.1093/jjco/hyq053. Epub 2010 May 5. Jpn J Clin Oncol. 2010. PMID: 20444747
High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K. Yamashita H, et al. Among authors: hayakawa k. Jpn J Clin Oncol. 2013 May;43(5):547-52. doi: 10.1093/jjco/hyt029. Epub 2013 Mar 8. Jpn J Clin Oncol. 2013. PMID: 23475536
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Tsumura H, Satoh T, Ishiyama H, Tabata K, Kotani S, Minamida S, Kimura M, Fujita T, Matsumoto K, Kitano M, Hayakawa K, Baba S. Tsumura H, et al. Among authors: hayakawa k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e385-92. doi: 10.1016/j.ijrobp.2011.04.026. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21664068 Clinical Trial.
2,156 results